IDH2 and glioblastoma: Given the increasing importance of molecular subtyping in glioblastoma (22), the WHO has classified glioblastoma into glioblastoma, IDH-wildtype, glioblastoma, IDH-mutant, and glioblastoma not otherwise specified (NOS) (14).